{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:17Z","timestamp":1787071037202,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To explore the occurrence and possible mechanism of colitis in Lewis mice treated with PD-1 inhibitor combined with platinum-containing dual drug chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>A Lewis lung cancer model of C57BL\/6 mice was established, randomly divided into the treatment group (group C, PD-1 inhibitor + Carboplatin (CARB) + Pemetrexed (PEM)) and model group (group B, normal saline), and a control group (group A, normal saline) was set up. Observe the changes in tumor-free weight, tumor volume, disease activity index (DAI), colon histopathology, identify serum interleukin (IL)-10, interferon (IFN)-\u03b3, the expression of claudin-1, and occludin mRNA in the colon in each animals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Compared with group A, the tumor-free weight of mice in B decreased (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), the content of IL-10 in serum increased (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01), the content of IFN-\u03b3 in serum decreased (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Compared with group B, the transplanted tumor volume in C was reduced (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), DAI scores of D4 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and D7 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) were increased, colonic histopathology analysis showed that colitis occurred, serum IL-10 content was decreased (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), IFN-\u03b3 content was increased (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), and the mRNA expression of claudin-1 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) and occludin (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) was reduced.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This treatment can inhibit the growth of transplanted tumors but will cause colitis in Lewis mice. The impairment of intestinal barrier function following administration cause an imbalance in the expression of pro-inflammatory and anti-inflammatory factors in the colon, thus causing colitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2078_22","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:01:58Z","timestamp":1693224118000},"page":"939-944","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Colitis induced by PD-1 inhibitor combined with platinum-containing dual drug chemotherapy in Lewis mice and its mechanism"],"prefix":"10.4103","volume":"19","author":[{"given":"Chunhai","family":"Li","sequence":"first","affiliation":[{"name":"Department of Radiology, The Qilu Hospital of Shandong University, Jinan Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Nursing and Rehabilitation, Shandong University, Jinan Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqian","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Qilu Hospital of Shandong University, Jinan Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Qilu Hospital of Shandong University, Jinan Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Xian","sequence":"additional","affiliation":[{"name":"Interventional Department, Jinan Central Hospital, Jinan Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, The Qilu Hospital of Shandong University, Jinan Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/jcrt.JCRT_710_19","article-title":"Induction chemotherapy for unresectable stage III non-small-cell lung cancer may improve survival of induction chemotherapy responders as predicted by elevated levels of carcinoembryonic antigen and cytokeratin fragment 19 and classification as stage N3 cancer","volume":"16","author":"Li","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4103\/jcrt.JCRT_1015_19","article-title":"A prospective observational study of chemotherapy-induced adverse drug reaction and the quality of life in cancer patients in a tertiary care hospital","volume":"17","author":"Krishnarajan","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1053\/gast.1996.v111.pm8898641","article-title":"SubstancePactivation of enteric neurons in response to intraluminal clostridium difficile toxin A in the rat ileum","volume":"111","author":"Mantyh","year":"1996","journal-title":"Gastroenterology"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1152\/ajpendo.90459.2008","article-title":"Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake","volume":"296","author":"Boukhettala","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4291\/wjgp.v11.i6.114","article-title":"Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases","volume":"11","author":"Muehler","year":"2020","journal-title":"World J Gastrointest Pathophysiol"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ccell.2020.08.007","article-title":"Nivolumab plus ipilimumab for metastatic castration-resistant prostate cancer:Preliminary analysis of patients in the checkmate 650 trial","volume":"38","author":"Sharma","year":"2020","journal-title":"Cancer Cell"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fonc.2020.00197","article-title":"Risk of gastrointestinal adverse events in cancer patients treated with immune checkpoint inhibitor plus chemotherapy:A systematic review and meta-analysis","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrgastro.2018.14","article-title":"Gastrointestinal toxicity of immune checkpoint inhibitors:From mechanisms to management","volume":"15","author":"Samaan","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/ecco-jcc\/jjv227","article-title":"Cancer immunotherapy with anti-CTLA-4 monoclonal antibodies induces an inflammatory bowel disease","volume":"10","author":"Marthey","year":"2016","journal-title":"J Crohns Colitis"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/MCB.06029-11","article-title":"Occludin:One protein, many forms","volume":"32","author":"Cummins","year":"2012","journal-title":"Mol Cell Biol"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.biopha.2018.11.095","article-title":"Traditional chinese medicine gegen qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice","volume":"109","author":"Wu","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02201-4","article-title":"Prevotellaceae produces butyrate to alleviate PD-1\/PD-L1 inhibitor-related cardiotoxicity via PPARalpha-CYP4X1 axis in colonic macrophages","volume":"41","author":"Chen","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/annonc\/mdg013","article-title":"Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy","volume":"14","author":"Alexandre","year":"2003","journal-title":"Ann Oncol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4103\/0973-1482.143345","article-title":"Prevalence of colorectal cancer in patients with ulcerative colitis:A retrospective, monocenter study in China","volume":"11","author":"Zhang","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/457036b","article-title":"Cancer:Inflaming metastasis","volume":"457","author":"Mantovani","year":"2009","journal-title":"Nature"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4103\/jcrt.jcrt_176_21","article-title":"High systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis","volume":"17","author":"Xu","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4103\/jcrt.JCRT_273_20","article-title":"Effect of oral supplements on the nutritional status of nasopharyngeal carcinoma patients undergoing concurrent chemotherapy:A randomized controlled Phase II trial","volume":"16","author":"Dou","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0167-5699(87)90171-X","article-title":"Two types of mouse helper T-cell clone Implications for immune regulation","volume":"8","author":"Mosmann","year":"1987","journal-title":"Immunol Today"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10:New perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol Rev"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2008.07.008","article-title":"Regulation of autoimmune inflammation by pro-inflammatory cytokines","volume":"120","author":"Kim","year":"2008","journal-title":"Immunol Lett"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1038\/ncomms10391","article-title":"Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis","volume":"7","author":"Dubin","year":"2016","journal-title":"Nat Commun"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"113271","DOI":"10.1016\/j.jep.2020.113271","article-title":"The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice","volume":"265","author":"Zhu","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy-driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"R27-20241021","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s40425-018-0461-4","article-title":"Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis:A multi-center study","volume":"6","author":"Abu-Sbeih","year":"2018","journal-title":"J Immunother Cancer"},{"key":"R28-20241021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000496426","article-title":"Beneficial effects of probiotic consumption on the immune system","volume":"74","author":"Galdeano","year":"2019","journal-title":"Ann Nutr Metab"},{"key":"R29-20241021","doi-asserted-by":"crossref","first-page":"G601","DOI":"10.1152\/ajpgi.00316.2020","article-title":"The role of butyrate in surgical and oncological outcomes in colorectal cancer","volume":"320","author":"Hajjar","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2078_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:37Z","timestamp":1787067637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2078_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2078_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"2022-10-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}